Kezar Life Sciences Inc. (KZR)
NASDAQ: KZR
· Real-Time Price · USD
3.90
0.04 (1.04%)
At close: Aug 19, 2025, 3:59 PM
3.87
-0.88%
After-hours: Aug 19, 2025, 04:58 PM EDT
1.04% (1D)
| Bid | 3.87 |
| Market Cap | 28.6M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -78.63M |
| EPS (ttm) | -9.7 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | -0.63 |
| Analyst | Hold |
| Ask | 4.24 |
| Volume | 80,008 |
| Avg. Volume (20D) | 48,532 |
| Open | 3.86 |
| Previous Close | 3.86 |
| Day's Range | 3.85 - 3.94 |
| 52-Week Range | 3.62 - 9.20 |
| Beta | 0.65 |
Analyst Forecast
According to 0 analyst ratings, the average rating for KZR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+42.1%
Kezar Life Sciences shares are trading higher afte...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Kezar Life Sciences to Participate in the Jefferies Global Healthcare ConferenceSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immun...
